Table 1.
Demographic and clinical characteristic of our participants
|
| |||||
|---|---|---|---|---|---|
| Parameters | Group | P value* | |||
| A†(n=52) | B‡ (n=199) | C ‡† (n=202) | |||
|
| |||||
| Age (Y) | 30.69 ± 5.06 | 30.86 ± 4.46 | 32.93 ± 4.67 | <0.001 | |
| Body mass index (kg/m2) | 26.30 ± 3.86 | 25.93 ± 3.60 | 26.23 ± 4.37 | 0.698 | |
| Duration of infertility (Y) | 6.50 ± 4.24 | 6.36 ± 4.16 | 6.47 ± 4.08 | 0.958 | |
| Cause of infertility | |||||
| Male factor | 22 (42.3) | 116 (58.3) | 106 (52.5) | 0.284 | |
| Tubal factor | 3 (5.8) | 7 (3.5) | 14 (6.9) | ||
| Anovulatory | 8 (15.4) | 28 (14.1) | 32 (15.8) | ||
| Recurrent abortion | 1 (1.9) | 2 (1.0) | 4 (2.0) | ||
| Unexplained factor | 6 (11.5) | 23 (11.6) | 27 (13.4) | ||
| Multi-factor | 12 (23.1) | 23 (11.6) | 19 (9.4) | ||
| Ovulation induction information | |||||
| No. of ampoules used | 25.86 ± 8.07 | 26.70 ± 10.61 | 26.81 ± 9.73 | 0.896 | |
| Length of ovarian stimulation (days) | 13.03 ± 3.34 | 13.02 ± 3.22 | 12.98 ± 3.23 | 0.990 | |
| Endometrial thickness on the day of hCG administration (mm) | 9.18 ± 1.69 | 9.66 ± 1.85 | 10.31 ± 2.12 | <0.001 | |
| No. of oocytes retrieved | 7.93 ± 3.51 | 8.88 ± 3.98 | 8.10 ± 3.97 | 0.250 | |
| No. of injected oocytes | 6.83 ± 3.45 | 7.09 ± 3.28 | 6.76 ± 3.64 | 0.761 | |
| Embryo’s information | |||||
| No. of 2PN embryos | 3.86 ± 2.51 | 4.50 ± 2.82 | 4.83 ± 2.91 | 0.244 | |
| No. of embryos transferred | 2.57 ± 0.66 | 2.42 ± 0.75 | 2.52 ± 0.74 | 0.226 | |
| No. of excellent and good quality embryos | 2.09 ± 0.91 | 2.02 ± 0.96 | 2.08 ± 0.91 | 0.729 | |
|
| |||||
Values are given as mean ± SD or n (%).†; Anterior-posterior myometrial diameter <25 mm, ‡; Anterior-posterior myometrial diameter between 25-29.9 mm, ‡†; Anterior-posterior myometrial diameter ≥30 mm, hCG; Human chorionic gonadotropin, 2PN; two-pronuclear, and *; Chi-square test for categorical variables and one-way analysis of variance for continuous variables.